307 related articles for article (PubMed ID: 35047242)
1. Medical cannabis use in Thailand after its legalization: a respondent-driven sample survey.
Assanangkornchai S; Thaikla K; Talek M; Saingam D
PeerJ; 2022; 10():e12809. PubMed ID: 35047242
[TBL] [Abstract][Full Text] [Related]
2. Trends in cannabis use among adults with children in the home in the United States, 2004-2017: impact of state-level legalization for recreational and medical use.
Goodwin RD; Kim JH; Cheslack-Postava K; Weinberger AH; Wu M; Wyka K; Kattan M
Addiction; 2021 Oct; 116(10):2770-2778. PubMed ID: 33730400
[TBL] [Abstract][Full Text] [Related]
3. Trends of cannabis use and related harms before and after legalization for recreational purpose in a developing country in Asia.
Kalayasiri R; Boonthae S
BMC Public Health; 2023 May; 23(1):911. PubMed ID: 37208663
[TBL] [Abstract][Full Text] [Related]
4. The impact of legalization of access to recreational Cannabis on Canadian medical users with Cancer.
Hawley P; Gobbo M; Afghari N
BMC Health Serv Res; 2020 Oct; 20(1):977. PubMed ID: 33109169
[TBL] [Abstract][Full Text] [Related]
5. Public opinion and medical cannabis policies: examining the role of underlying beliefs and national medical cannabis policies.
Sznitman SR; Bretteville-Jensen AL
Harm Reduct J; 2015 Oct; 12():46. PubMed ID: 26467203
[TBL] [Abstract][Full Text] [Related]
6. Cannabis use for symptom relief in multiple sclerosis: A cross-sectional survey of webinar attendees in the US and Canada.
Hildebrand A; Minnier J; Cameron MH
Mult Scler Relat Disord; 2020 Feb; 38():101516. PubMed ID: 31855842
[TBL] [Abstract][Full Text] [Related]
7. Medical cannabis use in the Australian community following introduction of legal access: the 2018-2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18).
Lintzeris N; Mills L; Suraev A; Bravo M; Arkell T; Arnold JC; Benson MJ; McGregor IS
Harm Reduct J; 2020 Jun; 17(1):37. PubMed ID: 32513180
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneities in administration methods among cannabis users by use purpose and state legalization status: findings from a nationally representative survey in the United States, 2020.
Shi Y
Addiction; 2021 Jul; 116(7):1782-1793. PubMed ID: 33217090
[TBL] [Abstract][Full Text] [Related]
9. Prices and Purchase Sources for Dried Cannabis Flower in the United States, 2019-2020.
Wadsworth E; Driezen P; Pacula RL; Kilmer B; Hammond D
Cannabis Cannabinoid Res; 2023 Oct; 8(5):923-932. PubMed ID: 35363550
[No Abstract] [Full Text] [Related]
10. Attitudes and Beliefs Toward Cannabis Before Recreational Legalization: A Cross-Sectional Study of Community Adults in Ontario.
Turna J; Balodis I; Van Ameringen M; Busse JW; MacKillop J
Cannabis Cannabinoid Res; 2022 Aug; 7(4):526-536. PubMed ID: 33998851
[No Abstract] [Full Text] [Related]
11. Consumer Experiences with Delta-8-THC: Medical Use, Pharmaceutical Substitution, and Comparisons with Delta-9-THC.
Kruger DJ; Kruger JS
Cannabis Cannabinoid Res; 2023 Feb; 8(1):166-173. PubMed ID: 34797727
[No Abstract] [Full Text] [Related]
12. Engagement with medical cannabis information from online and mass media sources: Is it related to medical cannabis attitudes and support for legalization?
Lewis N; Sznitman SR
Int J Drug Policy; 2019 Nov; 73():219-227. PubMed ID: 30799152
[TBL] [Abstract][Full Text] [Related]
13. The impact of cannabis legalization and decriminalization on acute poisoning: A systematic review.
Allaf S; Lim JS; Buckley NA; Cairns R
Addiction; 2023 Dec; 118(12):2252-2274. PubMed ID: 37496145
[TBL] [Abstract][Full Text] [Related]
14. Understanding Public Attitudes Toward Cannabis Legalization: Qualitative Findings From a Statewide Survey.
Resko S; Ellis J; Early TJ; Szechy KA; Rodriguez B; Agius E
Subst Use Misuse; 2019; 54(8):1247-1259. PubMed ID: 30999800
[TBL] [Abstract][Full Text] [Related]
15. Legalization of marijuana or not? Opinions from over 38,000 residents in Taiwan.
Chao KY; Liu SH; Chou CC; Chen CI; Cheng W
BMC Public Health; 2023 Oct; 23(1):1954. PubMed ID: 37814243
[TBL] [Abstract][Full Text] [Related]
16. Changes in cannabis use, exposure, and health perceptions following legalization of adult recreational cannabis use in California: a prospective observational study.
Gali K; Winter SJ; Ahuja NJ; Frank E; Prochaska JJ
Subst Abuse Treat Prev Policy; 2021 Feb; 16(1):16. PubMed ID: 33579324
[TBL] [Abstract][Full Text] [Related]
17. Consumer perceptions of legal cannabis products in Canada, 2019-2021: a repeat cross-sectional study.
Wadsworth E; Fataar F; Goodman S; Smith DM; Renard J; Gabrys R; Jesseman R; Hammond D
BMC Public Health; 2022 Nov; 22(1):2048. PubMed ID: 36348479
[TBL] [Abstract][Full Text] [Related]
18. Perceptions of cannabis use risk to mental health among youth in Canada, England and the United States from 2017 to 2021.
Lemos MK; Taylor E; Wadsworth E; Reid JL; Hammond D; East K
Drug Alcohol Depend; 2023 Sep; 250():110904. PubMed ID: 37549543
[TBL] [Abstract][Full Text] [Related]
19. How have cannabis use and related indicators changed since legalization of cannabis for non-medical purposes? Results of the Canadian Cannabis Survey 2018-2022.
Goodman S; Dann MJ; Fataar F; Abramovici H
Int J Drug Policy; 2024 May; 127():104385. PubMed ID: 38520961
[TBL] [Abstract][Full Text] [Related]
20. Current cannabis-related situation in the Asia-Pacific region.
Areesantichai C; Perngparn U; Pilley C
Curr Opin Psychiatry; 2020 Jul; 33(4):352-359. PubMed ID: 32459704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
